Owner Allergan, Inc.

Inventors Ruiz, Guadalupe; Spada, Lon T.; Hughes, Patrick M.; Lin, Joan-En; Whitcup, Scott M.; Robinson, Michael R.; Blanda, Wendy M.; Welty, Devin F.; Orilla, Werhner C.

Agent Davies Collison Cave

Pub. Number AU-A-2007329723

PCT Pub. Number WO2008/070402

Priority 11/565,917 01.12.06 US

Filing date 9 November 2007

Wipo publication date 12 June 2008

A61F 2/14 (2006.01) Filters - Eye parts, e.g. lenses, corneal implants

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates